Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anna Wesołowska, Magdalena Jastrzębska-Więsek, Agnieszka Cios & Anna Partyka. (2020) The preclinical discovery and development of paliperidone for the treatment of schizophrenia. Expert Opinion on Drug Discovery 15:3, pages 279-292.
Read now
Read now
Georgios Schoretsanitis, Edoardo Spina, Christoph Hiemke & Jose de Leon. (2018) A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone. Expert Review of Clinical Pharmacology 11:6, pages 625-639.
Read now
Read now
Rosaria Di Lorenzo, Michela Cameli, Chiara Piemonte, Marisa Bolondi, Giulia Landi, Gabriella Pollutri, Ludovica Spattini, Valentina Moretti & Paola Ferri. (2018) Clinical improvement, relapse and treatment adherence with paliperidone palmitate 1-month formulation: 1-year treatment in a naturalistic outpatient setting. Nordic Journal of Psychiatry 72:3, pages 214-220.
Read now
Read now
Pierre Chue & James Chue. (2016) A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder. Therapeutics and Clinical Risk Management 12, pages 109-116.
Read now
Read now
Ahmed Naguy & Ali Al-Tajali. (2016) Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia. Nordic Journal of Psychiatry 70:4, pages 318-319.
Read now
Read now
P. Chue, A. Malla, R.-H. Bouchard, S. Lessard, S. Ganesan, E. Stip, S. Johnson, E. Chen, Y.M. Ahn, Y.S. Kim, G. Robinson, C. Schweikert, A. Gendron & H. Eriksson. (2013) The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia. Current Medical Research and Opinion 29:3, pages 227-239.
Read now
Read now
Articles from other publishers (9)
Louise Beilby & Lucy Arno. (2023) A case of extrapyramidal side effects due to possible paliperidone: voriconazole interaction. Journal of Pharmacy Practice and Research.
Crossref
Crossref
Maike Scherf-Clavel, Pierre Baumann, Xenia M. Hart, Heike Schneider, Georgios Schoretsanitis, Werner Steimer, Gerald Zernig & Gabriela Zurek. (2023) Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective. Therapeutic Drug Monitoring Publish Ahead of Print.
Crossref
Crossref
Jun-Pil Jee, Young Hoon Kim, Jun Hak Lee, Kyoung Ah Min, Dong-Jin Jang, Sung Giu Jin & Kwan Hyung Cho. (2023) Paliperidone–Cation Exchange Resin Complexes of Different Particle Sizes for Controlled Release. Pharmaceutics 15:3, pages 932.
Crossref
Crossref
Natasa Borojevic, Midya Dawud, Junhua Xiao & Yang Yun. (2022) Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report. BMC Psychiatry 22:1.
Crossref
Crossref
Gang Wang, Fan Ding, Marek Cezary Chawarski, Wei Hao, Xuebing Liu, Qijian Deng & Xuan Ouyang. (2020) Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients. Frontiers in Psychiatry 11.
Crossref
Crossref
Pei-Yin Pan, Meei-Shyuan Lee & Chin-Bin Yeh. (2015) The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population. BMC Psychiatry 15:1.
Crossref
Crossref
En-Chi Yeh, Ming-Chyi Huang, Chang-Jer Tsai, Chun-Tse Chen, Kuan-Yu Chen & Chih-Chiang Chiu. (2015) Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-release. Psychiatry Research 230:1, pages 13-18.
Crossref
Crossref
Gudrun Hefner, Tanja Falter, Kai Bruns & Christoph Hiemke. (2015) Elevated risperidone serum concentrations during acute inflammation, two cases. The International Journal of Psychiatry in Medicine 50:3, pages 335-344.
Crossref
Crossref
Guangjing Li, Yongjun Wang, Hongming Chen, Donglei Leng, Panqin Ma, Yanjie Dong, Lifang Gao & Zhonggui He. (2015) Can semipermeable membranes coating materials influence in vivo performance for paliperidone tri-layer ascending release osmotic pump tablet: In vitro evaluation and in vivo pharmacokinetics study. Asian Journal of Pharmaceutical Sciences 10:2, pages 128-137.
Crossref
Crossref